Cargando…

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor

Inflammatory myofibroblastic tumors (IMTs) are locally aggressive malignancies occurring at various sites. Surgery is the mainstay of treatment and prognosis is generally good. For children with unresectable or metastatic tumors, however, outcome is particularly severe, limited also by the lack of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonvini, Paolo, Rossi, Elisabetta, Zin, Angelica, Manicone, Mariangela, Vidotto, Riccardo, Facchinetti, Antonella, Tombolan, Lucia, Affinita, Maria Carmen, Santoro, Luisa, Zamarchi, Rita, Bisogno, Gianni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116882/ https://www.ncbi.nlm.nih.gov/pubmed/33996693 http://dx.doi.org/10.3389/fped.2021.652583

Ejemplares similares

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2022)

Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared
por: Rossi, Elisabetta, et al.
Publicado: (2020)

Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner
por: Tombolan, Lucia, et al.
Publicado: (2020)

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2020)

Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
por: Poli, Elena, et al.
Publicado: (2020)

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness
por: Poli, Elena, et al.
Publicado: (2022)

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients
por: Rossi, Elisabetta, et al.
Publicado: (2013)

Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance
por: Poli, Elena, et al.
Publicado: (2021)

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma
por: Bonvini, P, et al.
Publicado: (2013)

Ultrasonic Manifestations of Mesenteric Inflammatory Myofibroblastic Tumors in Children
por: Qian, Jingjing, et al.
Publicado: (2019)

Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study
por: Marconato, Laura, et al.
Publicado: (2019)

NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2017)

Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation
por: Ogata, Misato, et al.
Publicado: (2018)

Inflammatory Myofibroblastic Tumors in the Uterus: Childhood-Case Report and Review of the Literature
por: Etlinger, Péter, et al.
Publicado: (2020)

Inflammatory Myofibroblastic Tumors in Children: A Clinical Retrospective Study on 19 Cases
por: Da, Min, et al.
Publicado: (2021)

Robot assisted laparoscopic partial cystectomy for inflammatory myofibroblastic tumor with simultaneous intraoperative flexible cystoscopy for tumor mapping
por: Batie, Shane F., et al.
Publicado: (2022)

Pulmonary Inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature
por: Camela, Federica, et al.
Publicado: (2018)

ALK negative inflammatory myofibroblastic tumor of the orbit: A masquerading entity
por: Dutta, Vibha, et al.
Publicado: (2014)

ALK Negative Inflammatory Myofibroblastic Tumor Synchronous with Classical Hodgkin Lymphoma
por: Sandoval, Letícia, et al.
Publicado: (2019)

MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA
por: Tombolan, Lucia, et al.
Publicado: (2015)

An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
por: Jacob, Sanjivini V., et al.
Publicado: (2014)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
por: Rossi, Elisabetta, et al.
Publicado: (2021)

Inflammatory Myofibroblastic Tumor of the Upper Airways Harboring a New TRAF3-ALK Fusion Transcript
por: Di Ruscio, Valentina, et al.
Publicado: (2021)

ALK Gene Translocation in Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
por: Takagi, Kimiaki, et al.
Publicado: (2015)

ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report
por: Wang, Kai, et al.
Publicado: (2018)

Inflammatory myofibroblastic tumor of the mesentery with a SQSTM1::ALK fusion responding to alectinib
por: Sunga, Cass G. G., et al.
Publicado: (2023)

Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case
por: Sachdev, Ritesh, et al.
Publicado: (2020)

Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Case Report: Unusual Clinical Presentation of a Rare Cardiac Inflammatory Myofibroblastic Tumor in Children: The Differential Diagnosis With Pediatric Emergencies
por: Bilotta, Clio, et al.
Publicado: (2021)

ALK(G1269A) mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor
por: Michels, Sebastian Y. F., et al.
Publicado: (2017)

Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing
por: Zhang, Chenlu, et al.
Publicado: (2020)

Case report: Uniportal video-assisted thoracoscopic sleeve lobectomy in a 6-year-old patient with inflammatory myofibroblastic tumor (IMT)
por: Geng, Zhen-Yang, et al.
Publicado: (2023)

Possible role of circulating tumor cells in early detection of lung cancer
por: Poggiana, Cristina, et al.
Publicado: (2020)

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
por: Pantano, Francesco, et al.
Publicado: (2020)

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2020)

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report
por: Nagumo, Yoshiyuki, et al.
Publicado: (2018)

ALK-negative urachal inflammatory myofibroblastic tumor in an elderly female: A case report: Erratum
Publicado: (2019)

ALK 1 Negative Inflammatory Myofibroblastic Tumor of the Ileum: A Rare Cause of Ileocecal Intussusception
por: Yagnik, Vipul D.
Publicado: (2020)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

ALK-positive gastric inflammatory myofibroblastic tumor in an adult with familial adenomatous polyposis and diffuse fundic polyposis
por: Fan, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m0c9556dvv9tuevvbjob0akgrh